The government will no longer provide free universal Covid-19 testing for most of the public from 1 April, as part of its plan for living with the virus. While people can currently still order lateral ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

Lateral flow tests (LFTs) are widely used across healthcare, food safety and environmental monitoring, providing rapid, on-site results. But challenges with sensitivity, flexibility and usability ...

High demand for lateral flow tests has resulted in supply issues, with many people unable to get their hands on the kits in recent days and pharmacies warning of “huge problems” with kit deliveries.

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...

In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...

CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

Nanoparticles are emerging as powerful tools for research, therapeutic, and diagnostic applications. In particular, their utility as lateral flow test probes has gained prominence amid the COVID-19 ...